The free Tier-1 foundation (sleep, exercise and study technique like spaced repetition and active recall)
Image 1 of 1 BPC-157 (body protection compound), is an endogenous, stable pentadecapeptide 15 amino acids first derived from gastric juices

Conservative combination protocol (if attempting) Rationale for conservative approach: No safety data available Both peptides slow gastric emptying significantly Risk of severe GI complications Start low, go slow principle Tirzepatide component: Follow standard FDA-approved titration Weeks 1-4: 2.5mg weekly Weeks 5-8: 5mg weekly Weeks 9-12: 7.5mg weekly Weeks 13-16: 10mg weekly Week 17+: 12.5mg weekly (or stay at 10mg) Some reach 15mg weekly (maximum) Cagrilintide component (reduced from standard): Start AFTER tirzepatide stabilized at therapeutic dose (week 13+) Week 13-16: 0.6mg weekly (lower than standard) Week 17-20: 1.2mg weekly Week 21-24: 1.8mg weekly (may be maximum tolerable) Consider 2.4mg only if tolerating perfectly Conservative dosing comparison: Why sequential is safer: Tirzepatide establishes baseline first Can attribute new side effects to cagrilintide Easier to manage one variable at a time Option to stop cagrilintide if intolerable Less overwhelming than both simultaneously Expected benefits: 18-25% total weight loss (conservative estimate) Potentially superior to tirzepatide alone (15-22%) But incremental benefit may be modest (3-5% additional) Use SeekPeptides to plan sequential peptide additions safely

However, taking a supplement probably wont improve your health in these areas if your levels are already sufficient
The mechanism behind Cagrilintide weight loss lies in its ability to enhance satiety and reduce meal frequency without the use of stimulants
(Weve all been there.) So when TB-500 peptides start showing up on your social media feed, promising faster healing, better recovery, and less inflammation, it makes complete sense to be curious